On February 17th, 2022 the Sino-EU PerMed project organised a stakeholder workshop with the aim to present the Personalised Medicine landscape in Europe and China, highlight the main challenges to scientific and technological collaboration and initiate a debate on how to strengthen research and innovation between the two Regions. As a result, the Sino-EU PerMed Consortium, together with the Science & Technology Expert Task Force, have elaborated a set of recommendations for policymakers which are presented in the Sino-EU PerMed Policy Brief.
The document addresses three topics:
- PM landscape in EU and China,
- Traditional Chinese Medicine in PM and
- Data sharing.
For each topic the barriers and needs are identified and corresponding recommendations are provided. The Policy Paper will also be presented in the upcoming S&T Webinar on Perspectives in Personalised Medicine: genomics, rare diseases, devices on September 13th.
For more information on the event and speakers please visit the Sino-EU PerMed Webpage.
The final agenda will be published soon.
Register now
SINO-EU PerMed has been granted for funding through the current EU Framework Programme for Research and Innovation ‘Horizon 2020’ under grant agreement no 874556.
